Last updated on May 2020

Safety and Efficacy of AMG 592 in Subjects With Active Systemic Lupus Erythematosus


Brief description of study

To evaluate the safety and tolerability of subcutaneous (SC) dose administrations of AMG 592 in participants with systemic lupus erythematosus (SLE)

Clinical Study Identifier: NCT03451422

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.